Archives of Plastic Surgery

Korean Society of Plastic and Reconstructive Surgeons (대한성형외과학회)
권호 표지

Prognosis of Malignant Melanoma on Lower Extremity

하지에 발생한 악성 흑색종의 예후

  • Kim, Ji Ye (Institute for Human Tissue Restoration Department of Plastic and Reconstructive Surgery, Yonsei University College of Medicine) ;
  • Lee, Won Jai (Institute for Human Tissue Restoration Department of Plastic and Reconstructive Surgery, Yonsei University College of Medicine) ;
  • Lew, Dae Hyun (Institute for Human Tissue Restoration Department of Plastic and Reconstructive Surgery, Yonsei University College of Medicine) ;
  • Rah, Dong Kyun (Institute for Human Tissue Restoration Department of Plastic and Reconstructive Surgery, Yonsei University College of Medicine) ;
  • Tark, Kwan Chul (Institute for Human Tissue Restoration Department of Plastic and Reconstructive Surgery, Yonsei University College of Medicine)
  • 김지예 (연세대학교 의과대학 성형외과학교실 인체조직복원 연구소) ;
  • 이원재 (연세대학교 의과대학 성형외과학교실 인체조직복원 연구소) ;
  • 유대현 (연세대학교 의과대학 성형외과학교실 인체조직복원 연구소) ;
  • 나동균 (연세대학교 의과대학 성형외과학교실 인체조직복원 연구소) ;
  • 탁관철 (연세대학교 의과대학 성형외과학교실 인체조직복원 연구소)
  • Published : 2009.07.15
⟨ Previous Next ⟩

Abstract

Purpose: Malignant melanoma is recognized as the most serious skin cancer. We examined anatomical distribution and 5 - year survival rate of each stage of malignant melanoma on lower leg. Methods: We retrospectively analyzed the medical records of 91 patients(46 males and 45 females) with malignant melanoma on lower leg from 1985 to 2008. Age, sex, anatomical distribution and 5 - year survival rates of each stage of malignant melanoma on lower leg were investigated. Also, 5 - year survival rates of each stage and invasion depth of malignant melanoma on heel pad were investigated. Results: On lower leg, most frequently 32 cases(35.1%) occurred on heel pad, 27 cases(29.7%) occurred on dorsum of foot, 18 cases(19.8%) in toe and 14 cases(15.4%) on others in lower leg. We used the excision margin as 3 ~ 5 cm. After wide excision, in stage III, IV, the patients underwent the immunologic / chemo - therapy. The incidences of each stage were 22 cases(24.2%) in stage I, 47(51.6%) in II, 17(18.7%) in III and 5(5.5%) in IV. The 5 - year survival rates of each stage were 85%, 53.2%, 47.1% and 40%. On heel pad, the incidences of each stage were 5 cases(15.6%) in stage I, 19 cases(59.4%) in II, 7 cases(21.9%) in III and 1 case(3.1%) in IV. The 5 - year survival rates of each stage were 80%, 63.2%, 42.9% and 100%. On heel pad, incidence of local recurrence was 2 and 5 - year survival rate of this case was 100%. And systemic recurrence was 9 and 5 - year survival rate of this case was 55.6%. Conclusion: The 5 - year survival rate of malignant melanoma on heel pad was higher than previous study. To maintain the weight - bearing function of foot, we recommend the active reconstructive surgery for heel pad reconstruction after wide excision of heel pad malignant melanoma.

Keywords

References

  1. Chudnovsky Y, Khavari PA, Adams AE: Melanoma genetics and the development of rational therapeutics. J Clin Invest 115: 813, 2005 https://doi.org/10.1172/JCI24808
  2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ: Cancer statistics, 2008. CA Cancer J Clin 58: 71, 2008 https://doi.org/10.3322/CA.2007.0010
  3. Rigel DS: Cutaneous ultraviolet exposure and its relationship to the development of skin cancer. J Am Acad Dermatol 58: S129, 2008 https://doi.org/10.1016/j.jaad.2007.04.034
  4. Shin JH, Cho SY, Whang KK, Hahm JH: An epidermiologic analysis of cutaneous malignant tumors over 15 years (1984-1998). Korean J Dermatol 37: 1743, 1999
  5. Ariel IM: Malignant melanoma of the lower extremity: evaluation of 453 patients. J Surg Oncol 15: 147, 1980 https://doi.org/10.1002/jso.2930150207
  6. Markovic SN, Erickson LA, Rao RD, Weenig RH, Pockaj BA, Bardia A, Vachoncm, Schild SE, McWilliams RR, Hand JL, Laman SD, Kottschade LA, Maples WJ, Pittelkow MR, Pulido JS, Cameron JD, Creagan ET; Melanoma Study Group of Mayo Clinic Cancer Center: Malignant melanoma in the 21st century, Part 2: Staging, prognosis, and treatment. Mayo Clin Proc 82: 490, 2007 https://doi.org/10.4065/82.4.490
  7. Clark WH Jr, From L, Bernardino EA, Mihm MC: The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 29: 705, 1969
  8. Breslow A: Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 172: 902, 1970 https://doi.org/10.1097/00000658-197011000-00017
  9. Chakera AH, Hansen LB, Lock-Andersen J, Drzewiecki KT, Hesse B: In-transit sentinel nodes must be found: implication from a 10-year follow-up study in melanoma. Melanoma Res 18: 359, 2008 https://doi.org/10.1097/CMR.0b013e328308da77
  10. Ben-Porat L, Panageas KS, Hanlon C, Patel A, Halpern A, Houghton AN, Coit D: Estimates of stage-specific survival are altered by changes in the 2002 American Joint Committee on cancer staging system for melanoma. Cancer 106: 163, 2006 https://doi.org/10.1002/cncr.21594
  11. Kwon YH, Kim JR, Lee YG, Kim JD: Analysis of treatment and prognosis in malignant melanoma. J Korean Bone & Joint Tumor Soc 11: 141, 2005
  12. Veronesi U, Cascinelli N, Adamus J, Balch C, Bandiera D, Barchuk A, Bufalino R, Craig P, Marsillac DJ, Durand JC: Thin stage i primary cutaneous malignant melanoma: comparison of excision with margins of 1 or 3cm. N Engl J Med 318: 1159, 1988 https://doi.org/10.1056/NEJM198805053181804
  13. Balchcm, Soong SJ, Smith T, Rose MI, Uristmm, Karakousis CP, Temple WJ, Mihm MC, Barnhill RL, Jewell WR, Wanebo HJ, Desmond R; Investiqators from the Interqroup Melanoma Surgical Trial: Long-term results of a prospective surgical trial comparing 2cm vs. 4cm excision margins for 740 patients with 1-4mm melanomas. Ann Surg Oncol 8: 101, 2001
  14. El-Shazly M, Yassin O, Kamal A, Makboul M, Gherardini G: Soft tissue defects of the heel: a surgical reconstruction algorithm based on a retrospective cohort study. J Foot Ankle Surg 47: 145, 2008 https://doi.org/10.1053/j.jfas.2007.12.010
  15. Moncrieff MD, Bowen F, Thompson JF, Saw RP, Shannon KF, Spillane AJ, Quinn MJ, Stretch JR: Keystone flap reconstruction of primary melanoma excision defects of the leg-the end of the skin graft? Ann Surg Oncol 15: 2867, 2008 https://doi.org/10.1245/s10434-008-0018-8